2Freitas D S, Sofia C, Pontes J M, et el. Octreotide in acute bleeding esophageal variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis [J]. Am J Gastroenterol,2000, 25: 768.
3Comar K M, Sanyal A J. Portal hypertensiove bleeding [J].Gastroenterol Clin North Am, 2003, 32: 1079.
4Zaman A. Current management of esophageal varices [J ].Curt Treat Options Gastroenterol, 2003, 6: 457.
5Abraldes J G, DellEra A, Bosch J. Medical management of varieeal bleeding in patients with cirrhosis [J]. Can J Gastroenterol, 2004, 18: 109.
1Freitas DS, Sofia C, Pontes JM, et al. Octreotide in acute bleeding esophageal varices: a prospective randomized study.Hepatogastroenterology, 2000, 47:1310-1314.
2Feu ET, Del Arbol, Banares R, et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology, 1996,111 : 1291-1299.
3Comar KM, Sanyal AJ. Portal hypertension bleeding.Gastroenterol Clin North Am, 2003, 32: 1079-1105.
4Zaman A. Current management of esophageal varices. Curr Treat Options Gastroenterol, 2003, 6: 499-457.
5Yillanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology, 2001, 121:110-117.
6Bildozola M, Kravetz D, Argonz T, et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol, 2000, 35 : 419-425.
